West Pharmaceutical Services Retained Earnings (Accumulated Deficit) 2010-2024 | WST

West Pharmaceutical Services retained earnings (accumulated deficit) for the quarter ending December 31, 2024 were $3.957B, a 12.29% increase year-over-year.

  • West Pharmaceutical Services retained earnings (accumulated deficit) for 2024 were $3.957B, a 12.29% increase from 2023.
  • West Pharmaceutical Services retained earnings (accumulated deficit) for 2023 were $3.523B, a 17.93% increase from 2022.
  • West Pharmaceutical Services retained earnings (accumulated deficit) for 2022 were $2.988B, a 21.62% increase from 2021.

West Pharmaceutical Services Retained Earnings (Accumulated Deficit) 2010-2024 | WST

  • West Pharmaceutical Services retained earnings (accumulated deficit) for 2024 were $3.957B, a 12.29% increase from 2023.
  • West Pharmaceutical Services retained earnings (accumulated deficit) for 2023 were $3.523B, a 17.93% increase from 2022.
  • West Pharmaceutical Services retained earnings (accumulated deficit) for 2022 were $2.988B, a 21.62% increase from 2021.